← Open Payments lookup

SHUREKKIA HUDGEN: Open Payments

NPI 1073127379 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,800 in 59 payments from 10 companies in 2025. Trend: 2023 $1,185 · 2024 $1,356 · 2025 $1,800

Food & beverage: $1,300Speaker / faculty: $500
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc4$573
Gilead Sciences, Inc.12$363
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$239
ABBVIE INC.12$211
Madrigal Pharmaceuticals10$184
Eisai Inc.5$149
ORPHALAN INC1$27
Intercept Pharmaceuticals, Inc.1$19
Takeda Pharmaceuticals U.S.A., Inc.1$19
Eton Pharmaceuticals, Inc.1$17

Products named: IQIRVO, XIFAXAN, MAVYRET, REZDIFFRA, Lenvima, Livdelzi, CUVRIOR, OCALIVA.

Industry payments across TX — which companies pay providers there.